NICE recommends the use of hybrid closed loop systems for those struggling to manage their type 1 diabetes.
New 'artificial pancreas' technology is set to change the lives of people unable to manage their type 1 diabetes, provided a cost-effective price is agreed, said the National Institute for Health and Care Excellence today.
These systems can eliminate finger prick tests and prevent life-threatening hypoglycaemic and hyperglycaemia attacks. NHS England had previously pointed out that figures show a 5-year-old child diagnosed with type 1 diabetes faces up to "23,000 insulin injections and 52,000 finger prick blood tests" by the time they are 18 years old.
Clinical trial and real-world evidence has shown that hybrid closed loop systems are "more effective than standard care" at maintaining blood glucose levels within a healthy range, NICE emphasised. For parents of children with diabetes, since children are "less able to recognise the symptoms of hypoglycaemia and hyperglycaemia", this is a "constant worry" for parents when they are apart from their children.
NICE also highlighted inequality issues related to family background and socioeconomic status, and that the automation offered by hybrid closed loop systems could help reduce some of the inequalities for people who find it difficult to maintain healthy blood glucose levels because of a language barrier, a lower level of education, or a learning disability, for example.
"At a time when the number of people with diabetes is rising, we have to focus on what matters most to people who use NHS services by balancing recommending the best care with value for money," explained Mark Chapman.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Diabetes artificial pancreas tech recommended for thousands on NHSIt can improve life for thousands with type 1 diabetes in England and Wales, health assessors say.
Les mer »
Artificial Pancreas Developed That Can Help Maintain Healthy Glucose Levels in Type 2 Diabetes PatientsArtificial Pancreas Successfully Trialed for Use by Type 2 Diabetes Patients Scientists at the University of Cambridge have successfully trialed an artificial pancreas for use by patients living with type 2 diabetes. The device – powered by an algorithm developed at the University of Cambridge – do
Les mer »
Generative artificial intelligence is driving tech's latest hype waveThe arrival of generative artificial intelligence technologies heralds a once-a-decade platform shift as big as the advent of the smartphone or the Web, many tech observers believe.
Les mer »
Inside plans for Copenhagen's divisive artificial storm-absorbing peninsulaA new 271-acre artificial peninsula is being built to shield Copenhagen from rising sea levels. But the environmental mission has drawn vocal criticism, primarily from those most concerned with the climate.
Les mer »
Why artificial intelligence will be big for business in 2023Insider tells the global tech, finance, markets, media, healthcare, and strategy stories you want to know.
Les mer »
New AI Technology Processes Photos to Let You Talk to Dead Loved OnesA South Korean artificial intelligence firm has begun offering a service that lets people talk to their dead loved ones.
Les mer »